U.S. and Canada External Defibrillators Market Research - 2031
The U.S. and Canada external defibrillators market size was valued at $1.12 billion in 2021 and is projected to reach $2 billion by 2031, registering a CAGR of 5.9% from 2022 to 2031. The U.S. and Canada external defibrillators market are experiencing a significant surge, primarily attributed to growing incidence of cardiovascular diseases. For instance, according to a 2023 article by Center of Disease control and Prevention it was estimated that every year, about 805,000 people in the U.S. have a heart attack. Moreover, the rise in incidence of diabetes, atherosclerosis, strokes, hypertension, and others due to lifestyle habits such as unhealthy dietary habits, lack of physical activity and smoking, among others, is the leading cause of congestive heart failure (CHF).
In addition, rise in geriatric population is also a major factor driving the growth of the market. For instance, according to 2022 article by World Health Organization, it was reported that the geriatric population will contribute around 22% of world population by 2050.
Key Takeaways
- By product type, the automated external defibrillator segment dominated the market in 2021.
- By end user, the hospitals segment dominated the market in 2021.
- Country wise, U.S. held the largest market share in 2021. However, Canada is expected to witness the highest CAGR during the forecast period.
The recession in 2023 is expected to have a significant impact on the U.S. and Canada external defibrillators market. The rising in inflation in North America and the economic uncertainty has resulted in the decrease in the investment for new product developments.
An external defibrillator is a portable medical device designed to deliver a therapeutic dose of electrical energy to the heart in order to restore normal heart rhythm in cases of cardiac arrhythmias, particularly ventricular fibrillation and pulseless ventricular tachycardia. These conditions can lead to sudden cardiac arrest, a life-threatening emergency where the heart stops beating effectively. External defibrillators are crucial tools in emergency medical situations, such as in hospitals, ambulances, and public places like airports and sports arenas.
Market Dynamics
The U.S. and Canada external defibrillators market share is expected to register significant growth owing to the surge in cardiovascular disease, rise in geriatric population, and technological advancement in the external defibrillators.
The surge in cardiovascular disease has emerged as a significant driver for the external defibrillators market in both the U.S. and Canada. This rise in cardiovascular conditions, including heart attacks and arrhythmias, has heightened the need for advanced medical equipment capable of providing rapid intervention and lifesaving measures. According to 2023 article by Center of Disease control and Prevention it was estimated that, in the U.S. a person has a heart attack every 40 seconds. External defibrillators have become indispensable tools in emergency medical situations, particularly in cases of sudden cardiac arrest, where immediate intervention is critical for patient survival.
As lifestyle factors, including sedentary habits, poor dietary choices, and increasing stress levels, continue to contribute to the prevalence of cardiovascular issues across both nations, the demand for reliable and accessible defibrillation devices has seen a notable rise. Additionally, aging populations in both countries are experiencing a higher incidence of cardiac-related incidents, further amplifying the necessity for accessible defibrillation equipment in various settings, including healthcare facilities, public spaces, and workplaces.
Furthermore, the U.S. and Canada external defibrillators market size is expected to register significant growth owing to rise in geriatric population. According to 2024 report by Population Reference Bureau, it was estimated that the number of Americans ages 65 and older is projected to increase from 58 million in 2022 to 82 million by 2050 (a 47% increase). As U.S. and Canada experience demographic shifts with aging populations, the prevalence of cardiac-related conditions, such as heart attacks and sudden cardiac arrests, also increases. Given that advanced age is a major risk factor for cardiovascular diseases, including arrhythmias, the demand for external defibrillators, crucial devices for restoring normal heart rhythms during emergencies, escalates.
The aging population often resides in healthcare settings, such as hospitals, nursing homes, and assisted living facilities, where external defibrillators are important medical device for intervention in cardiac emergencies. Consequently, healthcare providers, institutions, and government agencies prioritize the deployment and accessibility of external defibrillators, contributing to market growth.
Technological advancements have emerged as a pivotal force driving the growth of the external defibrillators market in both the U.S. and Canada. These advancements have significantly enhanced the efficiency, reliability, and accessibility of defibrillation technology, thereby revolutionizing the management of sudden cardiac arrest (SCA) cases. One of the notable advancements is the development of automated external defibrillators (AEDs), which are user-friendly devices equipped with intelligent algorithms capable of analyzing heart rhythms and delivering electric shocks when necessary. New advancements in defibrillators come with higher success rates, depending on its usage in treating cardiac arrest. Public access defibrillators are the new developments for mass implementation to prevent SCA anytime, anywhere.
Implantable devices have been used since decades to treat heart diseases. For instance, Zoll offers wearable external defibrillators named LifeVest, which allows physicians to take proper time for the assessment of patient’s long-term arrhythmic risk and take proper decisions for the treatment. Other advancements such as 12-lead electrocardiograms (ECGs), additional vital signs data and remote wireless transmission has spurred the market growth. The key providers of these devices are Philips, Physio-Control, and Zoll. Furthermore, innovations in these devices such as miniaturization to reduce the size and introduction of MRI pacemakers, biocompatible materials, and durable batteries are offering a new era in the management of heart failure patients. These technologies are mostly preferred over others, due to their remarkable results. Moreover, technological advanced treatment devices with improved results have boosted the market growth.
However, the safety concerns related to automated external defibrillator might restrain the growth of the market. Although automated external defibrillators are widely adopted to meet the need for preventing sudden cardiac arrest at public places especially. These defibrillators are designed for the public places to be used by layman. These defibrillators are placed across all the public places, where the crowd gathers such as airports, railway station, malls, schools, offices, hospitals and others. These devices apply high-energy pulse of electricity to the heart muscle of the patients who suffer from sudden cardiac arrest at public places. Sometimes the electric dose fluctuates while used by non-medical personnel at public places.
Segments Overview
The U.S. and Canada external defibrillators market is segmented on the basis of product type and end user. On the basis of product type, the market is classified into manual external defibrillator, automated external defibrillators, and wearable cardioverter defibrillator. The automated external defibrillator segment is further divided into semi-automated external defibrillator and fully automated defibrillator. On the basis of end user, the market is classified into hospitals, pre-hospitals, public access market, alternate care market, and home.
Major key players that operate in the U.S. and Canada external defibrillators market are Asahi Kasei Corporation, CU Medical Germany GmbH, General Electric Company, Mediana Co., Ltd., Nihon Kohden Corporation, Koninklijke Philips N.V., Schiller AG, Shenzhen Comen Medical Instruments Co., Ltd., Shenzhen Mindray BioMedical Electronics Co., Ltd., and Stryker Corporation.
By Product Type
On the basis of product type, the U.S. and Canada external defibrillators market is divided into manual external defibrillator, automated external defibrillators, and wearable cardioverter defibrillator. The automated external defibrillators segment was the largest revenue contributor in 2021, and is expected to remain dominant during the forecast period. This is attributed to increase in its installations at public places such as schools, workplace, airports, sports arenas, government offices, and other public or private places.
By Product Type
Automated External Defibrillator segment held a dominant position in 2021 and is anticipated to grow at a fastest rate during the forecast period.
By End User
On the basis of end user, the market is segmented into hospitals, pre-hospitals, public access market, alternate care market, and home. The hospitals segment were the largest revenue contributor in 2021, owing to the fact that hospital cater large number of patients suffering from cardiovascular dieseases. However, alternate care market segment is expected to register fastest growth during the forecast period. This is attributed to rise in population suffering from cardiovascular diseases and increase in number of sudden cardiac arrests.
By End User
Hospitals segment held a dominant position in 2021. However alternative care market segmentis anticipated to grow at a fastest rate during the forecast period.
Competitive Analysis
Competitive analysis and profiles of the major players in the U.S. and Canada external defibrillators market opportunity, such as Asahi Kasei Corporation, CU Medical Germany GmbH, General Electric Company, Mediana Co., Ltd., Nihon Kohden Corporation, Koninklijke Philips N.V., Schiller AG, Shenzhen Comen Medical Instruments Co., Ltd., Shenzhen Mindray BioMedical Electronics Co., Ltd., and Stryker Corporation. Major players have adopted acquisition as a key developmental strategy to improve the product portfolio and gain a strong foothold in the U.S. and Canada external defibrillators market.
Recent Developments in U.S. and Canada external defibrillators market
- In December 2021, ZOLL Medical Corporation, which manufactures defibrillators and Asahi Kasei completed its acquisition of Itamar Medical Ltd. The acquisition of Itamar is expected to help Asahi strengthen their product portfolio in the segment of cardiology and sleep medicines.
U.S. and Canada External Defibrillators Market Report Highlights
| Aspects | Details |
 By Product Type |
|
 By End User |
|
 By Country |
|
 Key Market Players | General Electric Company, Shenzhen Comen Medical Instruments Co., Ltd., Asahi Kasei Corporation, Stryker Corporation., Nihon Kohden Corporation, CU Medical Germany GmbH, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Schiller AG, Koninklijke Philips N.V., Mediana Co., Ltd. |
Analyst Review
According to the insights of CXOs, growth of the U.S. and Canada external defibrillator market is attributed to factors such as rise in new product launches, technological advancements in defibrillator devices, and increase in awareness about sudden cardiac arrest. For instance, in February 2023, Medtronic plc, a global leader in medical device industry has received the Conformité Europeenne (CE), mark approval for its Aurora EV-ICD MRI SureScan and and Epsila EV MRI SureScan defibrillation. Thus, increase in new product approvals and rise in incidences of sudden cardiac arrest drive the growth of external defibrillators market in the U.S. and Canada.
The total market value of U.S. and Canada External Defibrillators Market is $1.12 billion in 2021.
The forecast period for U.S. and Canada External Defibrillators Market is 2022-2031.
The market value of U.S. and Canada External Defibrillators Market in 2032 is expected to be $2 billion.
The base year is 2021 in U.S. and Canada External Defibrillators Market
Major key players that operate in the U.S. and Canada External Defibrillators Market are Asahi Kasei Corporation, CU Medical Germany GmbH, General Electric Company, Koninklijke Philips N.V.
The automated external defibrillator segment is the most influencing segment in the U.S. and Canada External Defibrillators Market.
The U.S. and Canada External Defibrillators Market growth is driven by increase in incidences of sudden cardiac arrest, technological advancements in the external defibrillator devices, and rise in awareness about cardiac health
External defibrillators are light weight and portable electronic devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia.
Loading Table Of Content...
